B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis

Experimental Neurology

Volumn 221, Issue 1, 2010, Pages 136-145

  Kala, Mrinalini ^a   Rhodes, Susan N ^a   Piao, Wen Hua ^a   Shi, Fu Dong ^a   Campagnolo, Denise I ^a   Vollmer, Timothy L ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

B cells; Experimental autoimmune encephalomyelitis; Glatiramer acetate Copaxone; Multiple sclerosis

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GLATIRAMER; INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; OVALBUMIN; PHOSPHATE BUFFERED SALINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL TRANSFER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG APPROVAL; DRUG MECHANISM; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PURIFICATION; RECIPIENT; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLYCOPROTEINS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS; PEPTIDES; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 72749096461     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.10.015     Document Type: Article

References (48)

1. Antel J., and Bar-Or A. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. J. Neuroimmunol. 180 (2006) 3-8
2. Bar-Or A., Oliveira E.M., Anderson D.E., Krieger J.I., Duddy M., O'Connor K.C., and Hafler D.A. Immunological memory: contribution of memory B cells expressing costimulatory molecules in the resting state. J. Immunol. 16 (2001) 5669-5677
3. Begolka W.S., and Miller S.D. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res. Immunol. 149 (1998) 771-781
4. Bettelli E., Baeten D., Jäger A., Sobel R.A., and Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116 (2006) 2393-2402
5. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
6. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., Sommer N., Hartung H.P., and Hemmer B. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 128 (2005) 1667-1676
7. Chan O., and Shlomchik M.J. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J. Immunol. 160 (1998) 51-59
8. Chang T.T., Jabs C., Sobel R.A., Kuchroo V.K., and Sharpe A.H. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J. Exp. Med. 190 (1999) 733-740
9. Chang T.T., Sobel R.A., Wei T., Ransohoff R.M., Kuchroo V.K., and Sharpe A.H. Recovery from EAE is associated with decreased survival of encephalitogenic T cells in the CNS of B7-1/B7-2-deficient mice. Eur. J. Immunol. 33 (2003) 2022-2032
10. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
11. Corcione A., Aloisi F., Serafini B., Capello E., Mancardi G.L., Pistoia V., and Uccelli. B-cell differentiation in the CNS of patients with multiple sclerosis. Autoimmun. Rev. 4 (2005) 549-554
12. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., Kim H.J., and Bar-Or A. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178 (2007) 6092-6099
13. Fife B.T., Griffin M.D., Abbas A.K., Locksley R.M., and Bluestone J.A. Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J. Clin. Invest. 116 (2006) 2252-2261
14. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., and Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3 (2002) 944-950
15. Fridkis-Hareli M., Teitelbaum D., Gurevich E., Pecht I., Brautbar C., Kwon O.J., Brenner T., Arnon R., and Sela M. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells-specificity and promiscuity. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4872-4876
16. Fu S., Zhang N., Yopp A.C., Chen D., Mao M., Chen D., Zhang H., Ding Y., and Bromberg J.S. TGF-beta induces Foxp3+ T-regulatory cells from CD4+ CD25- precursors. Am. J. Transplant. 4 (2004) 1614-1627
17. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., Johnson L.L., Swain S.L., and Lund F.E. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1 (2000) 475-482
18. Hauser S.S.L., Waubant W., Arnold D.L., Vollmer T., et al. for HERMES Trial Group. B Cell Depletion with rituximab in relapsing remitting multiple sclerosis. NEJM 358 (2008) 676-678
19. Hjelmström P., Juedes A.E., Fjell J., and Ruddle N.H. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161 (1998) 4480-4483
20. Hong J., Li N., Zhang X., Zheng B., and Zhang J.Z. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 6449-6454
21. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
22. + regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin. Immunol. 125 (2007) 34-42
23. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderón-Gómez E., Sweenie C.H., Hao Y., Freitas A.A., Steinhoff U., Anderton S.M., and Fillatreau S. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180 (2008) 4763-4773
24. Lund F.E., Garvy B.A., Randall T.D., and Harris D.P. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. Curr. Dir. Autoimmun. 8 (2005) 25-54
25. Magliozzi R., Columba-Cabezas S., Serafini B., and Aloisi F. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 148 (2004) 11-23
26. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., and Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130 (2007) 1089-1104
27. Mann M.K., Maresz K., Shriver L.P., Tan Y., and Dittel B.N. B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J. Immunol. 178 (2007) 3447-3456
28. Martin R., McFarland H.F., and McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10 (1992) 153-187
29. Matsushita T., Fujimoto M., HaseGawa M., Komura K., Takehara K., Tedder T.F., and Sato S. Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am. J. Pathol. 168 (2006) 812-821
30. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., and Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 118 (2008) 3420-3430
31. Miller S.D., and Karpus W.J. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today 15 (1994) 356-361
32. Mizoguchi A., and Bhan A.K. A case for regulatory B cells. J. Immunol. 176 (2006) 705-710
33. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple Sclerosis. N. Engl. J. Med. 343 (2000) 938-952
34. Owens T., and Sriram S. The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. Neurol. Clin. 13 (1995) 51-73
35. Peterson L.K., Tsunoda I., and Fujinami R.S. Role of CD5+ B-1 cells in EAE pathogenesis. Autoimmunity 41 (2008) 353-362
36. Putheti P., Soderstrom M., Link H., and Huang Y.M. Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis. J. Neuroimmunol. 144 (2003) 125-131
37. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 21 (2003) 305-334
38. Seamons A., Perchellet A., and Goverman J. Endogenous myelin basic protein is presented in the periphery by both dendritic cells and resting B cells with different functional consequences. J. Immunol. 177 (2006) 2097-2106
39. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., and Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 14 (2004) 164-174
40. Serreze D.V., Fleming S.A., Chapman H.D., Richard S.D., Leiter E.H., and Tisch R.M. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161 (1998) 3912-3918
41. Shlomchik M.J., Craft J.E., and Mamula M.J. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1 (2001) 147-153
42. Simson D., Noble S., and Perry C. CNS Drugs 16 (2002) 825-850
43. Vieira P.L., Heystek H.C., Wormmeester J., Wieren E.A., and Kapsenberg M.L. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 170 (2003) 4483-4488
44. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
45. Weber M.S., Prod'homme T., Youssef S., Dunn S.E., Rundle C.D., Lee L., Patarroyo J.C., Stüve O., Sobel R.A., Steinman L., and Zamvil S.S. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 13 (2007) 935-943
46. Whitmore A.C., Haughton G., and Arnold L.W. Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int. Immunol. 8 (1996) 533-542
47. Wolf S.D., Dittel B.N., Hardardottir F., and Janeway Jr. C.A. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184 (1996) 2271-2278
48. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., and Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28 (2008) 639-650